About Cleerly
Cleerly provides an AI-driven platform that quantifies and assesses coronary artery disease (CAD) to deliver clinically actionable insights through a web-based solution. Its software analyzes and characterizes plaque, calculates stenosis, and detects likely ischemia in specific vessels. Cleerly's customers include healthcare providers, payors, and patients. The company offers its solutions through software demonstrations and aims to empower personalized treatment decisions.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Series-B+ announced
fundraisingfox.com
- Capital Raise
Raised $106,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Series-B+ announced
- Milestone
X account created (@Cleerlyhealth)
3.0K followers
- Milestone
Company founded
Denver, United States
- Milestone
Website domain registered
cleerly.com
Investors & Backers
Funding History
Founders & Leadership
Amit Relia
VP of Regulatory Affairs and Quality Assurance
Brandon Atkinson
Chief Operating Officer
James Min
Founder
James P Earls
Chief Medical Officer
Jim Hartman
Chief Revenue Officer
Kimberly McCombs
Chief Strategy Officer
Nick Nieslanik
Chief Technology Officer
Udo Hoffmann
Chief Medical, Scientific and AI Officer
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com